169 related articles for article (PubMed ID: 30803878)
1. The effects of antifungal stewardship programs at a tertiary-care teaching hospital in Japan.
Kawaguchi H; Yamada K; Imoto W; Yamairi K; Shibata W; Namikawa H; Yoshii N; Nakaie K; Okada Y; Fujita A; Shinoda Y; Nakamura Y; Kaneko Y; Nagayama K; Kakeya H
J Infect Chemother; 2019 Jun; 25(6):458-462. PubMed ID: 30803878
[TBL] [Abstract][Full Text] [Related]
2. Antifungal treatment in haematological and oncological patients: Need for quality assessment in routine care.
Lachenmayr SJ; Berking S; Horns H; Strobach D; Ostermann H; Berger K
Mycoses; 2018 Jul; 61(7):464-471. PubMed ID: 29575106
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Effects of Phased Implementation of Antimicrobial Stewardship in Academic ICUs: 2007-2015.
Morris AM; Bai A; Burry L; Dresser LD; Ferguson ND; Lapinsky SE; Lazar NM; McIntyre M; Matelski J; Minnema B; Mok K; Nelson S; Poutanen SM; Singh JM; So M; Steinberg M; Bell CM
Crit Care Med; 2019 Feb; 47(2):159-166. PubMed ID: 30407951
[TBL] [Abstract][Full Text] [Related]
4. Impact of a non-compulsory antifungal stewardship program on overuse and misuse of antifungal agents in a tertiary care hospital.
Markogiannakis A; Korantanis K; Gamaletsou MN; Samarkos M; Psichogiou M; Daikos G; Sipsas NV
Int J Antimicrob Agents; 2021 Jan; 57(1):106255. PubMed ID: 33279582
[TBL] [Abstract][Full Text] [Related]
5. How can we optimise antifungal use in a solid organ transplant centre? Local epidemiology and antifungal stewardship implementation: A single-centre study.
Mularoni A; Adamoli L; Polidori P; Ragonese B; Gioè SM; Pietrosi A; Tuzzolino F; Guadagnino G; Monaco F; Grossi PA; Conaldi PG; Luca A; Mikulska M
Mycoses; 2020 Jul; 63(7):746-754. PubMed ID: 32358860
[TBL] [Abstract][Full Text] [Related]
6. Effect of an antimicrobial stewardship programme on antimicrobial utilisation and costs in patients with leukaemia: a retrospective controlled study.
So M; Mamdani MM; Morris AM; Lau TTY; Broady R; Deotare U; Grant J; Kim D; Schimmer AD; Schuh AC; Shajari S; Steinberg M; Bell CM; Husain S
Clin Microbiol Infect; 2018 Aug; 24(8):882-888. PubMed ID: 29138099
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of the impact of antifungal stewardship interventions in the United States.
Hart E; Nguyen M; Allen M; Clark CM; Jacobs DM
Ann Clin Microbiol Antimicrob; 2019 Aug; 18(1):24. PubMed ID: 31434563
[TBL] [Abstract][Full Text] [Related]
8. Impact of infectious diseases consultation as a part of an antifungal stewardship programme on candidemia outcome in an Italian tertiary-care, University hospital.
Menichetti F; Bertolino G; Sozio E; Carmignani C; Rosselli Del Turco E; Tagliaferri E; Sbrana F; Ripoli A; Barnini S; Desideri I; Dal Canto L; Tascini C;
J Chemother; 2018 Sep; 30(5):304-309. PubMed ID: 30843776
[TBL] [Abstract][Full Text] [Related]
9. Improving quality of antifungal use through antifungal stewardship interventions.
Lachenmayr SJ; Strobach D; Berking S; Horns H; Berger K; Ostermann H
Infection; 2019 Aug; 47(4):603-610. PubMed ID: 30805898
[TBL] [Abstract][Full Text] [Related]
10. Antifungal stewardship in a tertiary-care institution: a bedside intervention.
Valerio M; Muñoz P; Rodríguez CG; Caliz B; Padilla B; Fernández-Cruz A; Sánchez-Somolinos M; Gijón P; Peral J; Gayoso J; Frias I; Salcedo M; Sanjurjo M; Bouza E;
Clin Microbiol Infect; 2015 May; 21(5):492.e1-9. PubMed ID: 25748494
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of education and antibiotic control programme at All India Institute of Medical Sciences, New Delhi.
Ahmed SA; Kumar A; Sethi P; Kapil A; Pandey RM; Wig N
Natl Med J India; 2018; 31(5):262-267. PubMed ID: 31267989
[TBL] [Abstract][Full Text] [Related]
12. [Inappropriate antifungal prescription and the need for antifungal stewardship programs].
Osorio-Lombana JP; Cuervo-Maldonado SI; López-Mora MJ; Gómez-Rincón JC
Rev Chilena Infectol; 2019 Aug; 36(4):403-413. PubMed ID: 31859762
[TBL] [Abstract][Full Text] [Related]
13. Changes in the utilization patterns of antifungal agents, medical cost and clinical outcomes of candidemia from the health-care benefit expansion to include newer antifungal agents.
Choi H; Kim JH; Seong H; Lee W; Jeong W; Ahn JY; Jeong SJ; Ku NS; Yeom JS; Kim YK; Kim HY; Song YG; Kim JM; Choi JY
Int J Infect Dis; 2019 Jun; 83():49-55. PubMed ID: 30959246
[TBL] [Abstract][Full Text] [Related]
14. Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era.
Agnelli C; Valerio M; Bouza E; Vena A; Guinea J; Del Carmen Martínez-Jiménez M; Marcos-Zambrano LJ; Escribano P; Muñoz P;
Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):607-614. PubMed ID: 30680572
[TBL] [Abstract][Full Text] [Related]
15. Impact of an infectious disease specialist on antifungal use: an interrupted time-series analysis in a tertiary hospital in Tokyo.
Morii D; Ichinose N; Yokozawa T; Oda T
J Hosp Infect; 2018 Jun; 99(2):133-138. PubMed ID: 29325870
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the prescription, consumption and costs of antifungal drugs in a pediatric hospital in Chile].
Barraza M; Barnafi N; Ortiz G; Torres JP; Coria P; Catalán P; Palma J; Morales J
Rev Chilena Infectol; 2018 Aug; 35(4):351-357. PubMed ID: 30534920
[TBL] [Abstract][Full Text] [Related]
17. Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis.
Cho SY; Lee DG; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH; Kim YJ; Kim HJ; Min WS; Back H; Kang S; Lee EK
Clin Ther; 2015 Sep; 37(9):2019-27. PubMed ID: 26188835
[TBL] [Abstract][Full Text] [Related]
18. Support for fungal infection treatment mediated by pharmacist-led antifungal stewardship activities.
Samura M; Hirose N; Kurata T; Ishii J; Nagumo F; Takada K; Koshioka S; Uchida M; Yamamoto S; Inoue J; Enoki Y; Taguchi K; Ishida A; Sekine H; Kunika N; Kunishima H; Matsumoto K
J Infect Chemother; 2020 Mar; 26(3):272-279. PubMed ID: 31732440
[TBL] [Abstract][Full Text] [Related]
19. Decreased antimicrobial resistance and defined daily doses after implementation of a clinical culture-guided antimicrobial stewardship program in a local hospital.
Wu CT; Chen CL; Lee HY; Chang CJ; Liu PY; Li CY; Liu MY; Liu CH
J Microbiol Immunol Infect; 2017 Dec; 50(6):846-856. PubMed ID: 26809591
[TBL] [Abstract][Full Text] [Related]
20. Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016.
Heimann SM; Vehreschild MJGT; Cornely OA; Heinz WJ; Grüner B; Silling G; Kessel J; Seidel D; Vehreschild JJ
J Hosp Infect; 2019 Mar; 101(3):339-346. PubMed ID: 30423409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
